Treatment of metastatic renal cell carcinoma with low-dose interleukin-2

被引：0
|
作者：
Takezawa, Yuta [1 ]
Izumi, Kouji [1 ]
Nohara, Takahiro [1 ]
Narimoto, Kazutaka [1 ]
Ueno, Satoru [1 ]
Kadono, Yoshihumi [1 ]
Kitagawa, Yasuhide [1 ]
Konaka, Hiroyuki [1 ]
Mizokami, Atsushi [1 ]
Namiki, Mikio [1 ]
机构：
[1] Kanazawa Univ, Dept Urol, Kanazawa, Ishikawa 9201192, Japan
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-6-8
引用
收藏
页码：145 / 145
页数：1
相关论文
共 50 条
  • [21] Can outpatient interleukin-2 and interferon replace high-dose interleukin-2 for metastatic renal cell carcinoma?
    Vieweg, J
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (04): : 192 - 193
  • [22] Long-term immunotherapy with low-dose interleukin-2 and interferon-α in the treatment of patients with advanced renal cell carcinoma
    Buzio, C
    Andrulli, S
    Santi, R
    Pavone, L
    Passalacqua, R
    Potenzoni, D
    Ferrozzi, F
    Giacosa, R
    Vaglio, A
    CANCER, 2001, 92 (09) : 2286 - 2296
  • [23] HIGH-DOSE INTERLEUKIN-2 IN THE THERAPY OF METASTATIC RENAL-CELL CARCINOMA
    PARKINSON, DR
    SZNOL, M
    SEMINARS IN ONCOLOGY, 1995, 22 (01) : 61 - 66
  • [24] High-dose interleukin-2 in metastatic disease: Renal cell carcinoma and melanoma
    Dutcher, J
    ONCOLOGY-NEW YORK, 2002, 16 (11): : 3 - 3
  • [25] Eosinophilia and pruritus with interleukin-2 treatment in patients with metastatic renal cell carcinoma
    Lee, Sung Ho
    Dasanu, Constantin
    Dutcher, Janice
    JOURNAL OF IMMUNOTHERAPY, 2006, 29 (06) : 639 - 639
  • [26] A RANDOMIZED STUDY OF LOW-DOSE INTERLEUKIN-2 SUBCUTANEOUS IMMUNOTHERAPY VERSUS INTERLEUKIN-2 PLUS INTERFERON-ALPHA AS FIRST LINE THERAPY FOR METASTATIC RENAL-CELL CARCINOMA
    LISSONI, P
    BARNI, S
    ARDIZZOIA, A
    ANDRES, M
    SCARDINO, E
    CARDELLINI, P
    DELLABITTA, R
    TANCINI, G
    TUMORI, 1993, 79 (06) : 397 - 400
  • [27] A phase II study of interferon alpha and low-dose subcutaneous interleukin-2 in advanced renal cell carcinoma
    Piga, A
    Giordani, P
    Quattrone, A
    Giulioni, M
    DeSignoribus, G
    Antognoli, S
    Cellerino, R
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1997, 44 (06) : 348 - 351
  • [28] IMMUNOLOGICAL STUDY OF HUMAN RECOMBINANT INTERLEUKIN-2 (LOW-DOSE) IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA
    MARUMO, K
    MURAKI, J
    UENO, M
    TACHIBANA, M
    DEGUCHI, N
    BABA, S
    JITSUKAWA, S
    HATA, M
    TAZAKI, H
    UROLOGY, 1989, 33 (03) : 219 - 225
  • [29] Clinical and immunomodulatory effects of bevacizumab and low-dose interleukin-2 in patients with metastatic renal cell carcinoma: results from a phase II trial
    Garcia, Jorge A.
    Mekhail, Tarek
    Elson, Paul
    Triozzi, Pierre
    Nemec, Cheryl
    Dreicer, Robert
    Bukowski, Ronald M.
    Rini, Brian I.
    BJU INTERNATIONAL, 2011, 107 (04) : 562 - 570
  • [30] METASTATIC RENAL-CELL CANCER TREATED WITH LOW-DOSE INTERLEUKIN-2 - A PHASE-II MULTICENTER STUDY
    STOTER, G
    FOSSA, SD
    RUGARLI, C
    SYMANN, M
    JASMIN, C
    ISRAEL, L
    BIJMAN, JT
    PALMER, P
    FRANKS, CR
    PHILIP, T
    CANCER TREATMENT REVIEWS, 1989, 16 : 111 - 113
12345